Skip to main content
Premium Trial:

Request an Annual Quote

SurroMed, Relocating to PPD s Digs, Trades Stock for Cancer Markers

Click here for an updated version of this story.


NEW YORK, July 17 - PPD has given SurroMed an undisclosed cash payment and a range of cancer biomarkers in exchange for $24 million worth of SurroMed's senior preferred stock, the companies said today.


SurroMed said it intends to use PPD's biomarkers to take a stab at cancer diagnostics, and that it also plans to seek to partner related cancer therapeutic opportunities."


PPD has also bought biomarker-discovery services from SurroMed over the next four years, and will become SurroMed's "non-exclusive representative" for sales of additional biomarker-discovery services.

Terms of the transaction also call for SurroMed to relocate to PPD's facility in Menlo Park, Calif. The transactions are expected to close next month.

"We believe that the collaboration with PPD will allow SurroMed to achieve positive cash flow and sustainability and to expand our leadership position in the field of biomarker discovery," Gordon Ringold, CEO and chairman of SurroMed, said in a statement.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.